
Pharmaceuticals & Healthcare · NSE / BSE
Incorporated in 1991, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products across a wide range of acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory. The company offers over 36 brands such as Manforce, Moxikind-CV, Amlokind-AT, Prega News, and Gudcef, supported by one of the largest distribution networks of medical representatives in India, with over 80% of doctors prescribing its formulations. Ranked 4th in domestic sales in FY2022, Mankind Pharma has received numerous awards, including The Best of Bharat Awards 2022, National Awards for Manufacturing Competitiveness Silver Medal 2021, and recognition for Best Design in Healthcare and performance management excellence.
Price Band
₹1026 – ₹1080
Issue Size
₹4326 Cr
Lot Size
13 shares
GMP
+16.7%
Est. Listing
₹1260
at current GMP
Subscribed
15.32x
overall
Open
25 Apr 2023
Close
27 Apr 2023
Allotment
4 May 2023
Refund
5 May 2023
Demat Credit
6 May 2023
Listing
9 May 2023